Evidence map›Paper›PMID 37080973›Full record

ArticleNature communications2023

Human CEACAM1 is targeted by a Streptococcus pyogenes adhesin implicated in puerperal sepsis pathogenesis.

Erin A Catton, Daniel A Bonsor, Carolina Herrera, Margaretha Stålhammar-Carlemalm, Mykola Lyndin, Claire E Turner, Jo Soden, Jos A G van Strijp, Bernhard B Singer, Nina M van Sorge and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Binding ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. The group AInfection and immunity · 2025
    Article
  6. The role of CEACAMs in neutrophil function.European journal of clinical investigation · 2024
    Review
  7. Structural aspects of CEACAM1 interactions.European journal of clinical investigation · 2024
    Review
  8. Evolution of CEACAM pathogen decoy receptors in primates.European journal of clinical investigation · 2024
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. CEACAM expression in anFrontiers in immunology · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 7 countries.

Erin A Catton *Centre for Bacterial Resistance Biology, Section of Molecular Microbiology, Department of Infectious Diseases, Imperial College London, London, SW7 2AZ, UK.
Daniel A Bonsor *University of Maryland, Baltimore, MD, 21201, USA.
Carolina HerreraSection of Immunology of Infection, Department of Infectious Disease, Imperial College London, London, W2 1NY, UK.
Margaretha Stålhammar-CarlemalmDepartment of Laboratory Medicine, Division of Medical Microbiology, Lund University, Lund, 223 62, Sweden.
Mykola LyndinSumy State University, Sumy, 40000, Ukraine.
Claire E TurnerThe School of Biosciences, The Florey Institute, The University of Sheffield, Sheffield, S10 2TN, UK.ORCID http://orcid.org/0000-0002-4458-9748
Jo SodenRetrogenix, Chinley, High Peak, SK23 6FJ, Chinley, UK.
Jos A G van StrijpDepartment of Medical Microbiology, UMC Utrecht, Utrecht, 3584 CX, The Netherlands.ORCID http://orcid.org/0000-0001-6253-0830
Bernhard B SingerInstitute of Anatomy, Medical Faculty, University of Duisburg-Essen, Essen, 45147, Germany.
Nina M van SorgeDepartment of Medical Microbiology, UMC Utrecht, Utrecht, 3584 CX, The Netherlands. n.m.vansorge@amsterdamumc.nl.ORCID http://orcid.org/0000-0002-2695-5863
Gunnar LindahlDepartment of Laboratory Medicine, Division of Medical Microbiology, Lund University, Lund, 223 62, Sweden. gunnar.lindahl@tmb.lth.se.ORCID http://orcid.org/0000-0002-5734-1864
Alex J McCarthyCentre for Bacterial Resistance Biology, Section of Molecular Microbiology, Department of Infectious Diseases, Imperial College London, London, SW7 2AZ, UK. a.mccarthy@imperial.ac.uk.ORCID http://orcid.org/0000-0002-4105-3737
University Medical Center Utrecht · NLImperial College London · GBLund University · SEAmsterdam University Medical Centers · NLSumy State University · UAUniversity of Maryland, Baltimore · USUniversity of Sheffield · GB

Funding

Biotechnology and Biological Sciences Research Council BB/V006495/1Medical Research Council MR/N014103
6 · The paper itself

Abstract

Life-threatening bacterial infections in women after childbirth, known as puerperal sepsis, resulted in classical epidemics and remain a global health problem. While outbreaks of puerperal sepsis have been ascribed to Streptococcus pyogenes, little is known about disease mechanisms. Here, we show that the bacterial R28 protein, which is epidemiologically associated with outbreaks of puerperal sepsis, specifically targets the human receptor CEACAM1. This interaction triggers events that would favor the development of puerperal sepsis, including adhesion to cervical cells, suppression of epithelial wound repair and subversion of innate immune responses. High-resolution structural analysis showed that an R28 domain with IgI3-like fold binds to the N-terminal domain of CEACAM1. Together, these findings demonstrate that a single adhesin-receptor interaction can drive the pathogenesis of bacterial sepsis and provide molecular insights into the pathogenesis of one of the most important infectious diseases in medical history.

Indexed as

Puerperal InfectionSepsisStreptococcal InfectionsAdhesins, BacterialAntigens, CDBacterial ProteinsCell Adhesion MoleculesFemaleHumansPregnancyStreptococcus pyogenesAdhesins, BacterialAntigens, CDBacterial ProteinsCD66 antigensCell Adhesion Molecules

Identifiers

PMID37080973
PMCPMC10119177
OpenAlexW4366549929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.